Departmentof Neurosurgery at Gifu University Graduate School of Medicine, Gifu, Japan.
J Stroke Cerebrovasc Dis. 2013 Jul;22(5):627-32. doi: 10.1016/j.jstrokecerebrovasdis.2011.11.006. Epub 2011 Dec 28.
The purpose of this study was to evaluate the efficacy of endovascular treatment (EVT) in elderly patients (≥ 75 years of age) with acute large-vessel occlusion (LVO).
A total of 229 patients with acute LVO treated by EVT in 2008 were registered from 68 medical centers in Japan. Among the total of 229 patients, 89 were elderly patients. We retrospectively investigated the treatment efficacy of EVT and patient outcome, and compared the parameters between the elderly and the nonelderly group.
Recanalization after EVT was equally obtained in both groups (P = .71). There was no significant difference in the favorable outcome (modified Rankin Scale [mRS] 0-2) between the elderly and nonelderly groups (30.3% vs 33.6%; P = .61), whereas poor outcome (mRS 5 and 6) was observed more in the elderly group than in the nonelderly group (48.3% vs 32.1%; P = .01). In patients with any recanalization (Thrombolysis in Myocardial Infarction grading system 1-3), the rates of favorable outcome in both groups were similar (39.7% vs 42.6%; P = .71). In contrast, in patients without recanalization, there was a significant difference in the poor outcome between the elderly and the nonelderly groups (76.2% vs 46.7%; P = .046). Symptomatic intracranial hemorrhage occurred in 6.7% in the elderly group and in 11.4% in the nonelderly group (P = .23).
The elderly population could achieve favorable outcomes comparable to the nonelderly population, especially when they achieve any recanalization by EVT. Elderly patients should not be excluded from recanalization therapy with EVT because of age.
本研究旨在评估血管内治疗(EVT)在急性大血管闭塞(LVO)老年患者(≥75 岁)中的疗效。
从日本 68 个医疗中心共登记了 2008 年接受 EVT 治疗的 229 例急性 LVO 患者。在总共 229 例患者中,有 89 例为老年患者。我们回顾性调查了 EVT 的治疗效果和患者预后,并比较了老年组和非老年组的参数。
两组患者 EVT 后再通率相同(P =.71)。老年组和非老年组之间的良好预后(改良 Rankin 量表[mRS]0-2)无显著差异(30.3%比 33.6%;P =.61),但老年组预后不良(mRS 5 和 6)的比例高于非老年组(48.3%比 32.1%;P =.01)。在任何再通患者(血栓溶解心肌梗死分级系统 1-3)中,两组的良好预后率相似(39.7%比 42.6%;P =.71)。相比之下,在未再通患者中,老年组和非老年组的预后不良差异有统计学意义(76.2%比 46.7%;P =.046)。老年组症状性颅内出血发生率为 6.7%,非老年组为 11.4%(P =.23)。
老年患者可以获得与非老年患者相当的良好预后,尤其是当他们通过 EVT 实现任何程度的再通时。不应因年龄而排除老年患者接受 EVT 再通治疗。